Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Common Equity (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Common Equity for 11 consecutive years, with -$1.7 million as the latest value for Q1 2026.

  • For Q1 2026, Common Equity rose 5.83% year-over-year to -$1.7 million; the TTM value through Feb 2026 reached -$1.7 million, up 5.83%, while the annual FY2025 figure was -$1.8 million, 33.89% down from the prior year.
  • Common Equity was -$1.7 million for Q1 2026 at Cannabis Suisse, up from -$1.8 million in the prior quarter.
  • The five-year high for Common Equity was -$196079.0 in Q3 2022, with the low at -$1.9 million in Q3 2024.
  • Historically, Common Equity has averaged -$995180.0 across 5 years, with a median of -$476975.0 in 2024.
  • The largest annual shift saw Common Equity rose 22.99% in 2022 before it tumbled 389.56% in 2024.
  • Over 5 years, Common Equity stood at -$226129.0 in 2022, then plummeted by 80.87% to -$409001.0 in 2023, then crashed by 358.64% to -$1.9 million in 2024, then increased by 5.87% to -$1.8 million in 2025, then grew by 1.52% to -$1.7 million in 2026.
  • Per Business Quant database, its latest 3 readings for Common Equity were -$1.7 million in Q1 2026, -$1.8 million in Q4 2025, and -$1.8 million in Q3 2025.